- Home
- TMQ vs CADL Comparison
TMQ vs CADL Comparison
Compare TMQ & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMQ
- CADL
- Stock Information
- Founded
- TMQ 2004
- CADL 1999
- Country
- TMQ Canada
- CADL United States
- Employees
- TMQ N/A
- CADL N/A
- Industry
- TMQ Precious Metals
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- TMQ Basic Materials
- CADL Health Care
- Exchange
- TMQ Nasdaq
- CADL Nasdaq
- Market Cap
- TMQ 226.7M
- CADL 250.0M
- IPO Year
- TMQ N/A
- CADL 2021
- Fundamental
- Price
- TMQ $1.88
- CADL $6.75
- Analyst Decision
- TMQ
- CADL Strong Buy
- Analyst Count
- TMQ 0
- CADL 5
- Target Price
- TMQ N/A
- CADL $21.40
- AVG Volume (30 Days)
- TMQ 638.4K
- CADL 1.1M
- Earning Date
- TMQ 07-10-2025
- CADL 08-12-2025
- Dividend Yield
- TMQ N/A
- CADL N/A
- EPS Growth
- TMQ N/A
- CADL N/A
- EPS
- TMQ N/A
- CADL N/A
- Revenue
- TMQ N/A
- CADL N/A
- Revenue This Year
- TMQ N/A
- CADL N/A
- Revenue Next Year
- TMQ N/A
- CADL N/A
- P/E Ratio
- TMQ N/A
- CADL N/A
- Revenue Growth
- TMQ N/A
- CADL N/A
- 52 Week Low
- TMQ $0.47
- CADL $3.79
- 52 Week High
- TMQ $2.09
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- TMQ 76.30
- CADL 67.45
- Support Level
- TMQ $1.30
- CADL $5.78
- Resistance Level
- TMQ $2.05
- CADL $7.25
- Average True Range (ATR)
- TMQ 0.13
- CADL 0.41
- MACD
- TMQ 0.05
- CADL 0.19
- Stochastic Oscillator
- TMQ 84.67
- CADL 82.94
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.